TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma

NCT04059224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Melanoma
Stage III Melanoma

Interventions

DRUG: Trametinib
DRUG: Dabrafenib

Sponsor

Universitair Ziekenhuis Brussel